The UAE government is effectively underwriting the country's next growth chapter with a massive open checkbook.
While the headline-grabbing AED 71.5bn federal budget for FY 25 is the largest in history, the AED 5.745bn carved out specifically for healthcare and prevention tells the real story. Earmarking 8% of federal spending for this sector is a calculated move to stabilize a rapidly expanding population.
Get this: a new Alpen Capital report project that healthcare spending will skyrocket to AED 151bn by 2029. That means it’ll be growing at a steady 6.7% clip every year across the 2024–2029 forecast period.
For a company such as Pure Health, major Abu Dhabi-based platform operating hospitals, clinics, diagnostic services, health insurance, and medical procurement, this is essentially a state-sponsored tailwind.
The maths is ambitious. The government is betting that the private sector will follow up with enough volume to justify these eye-watering valuations.
The numbers for Pure Health in FY 25 show a company that is finally moving beyond its "buying spree" phase. Bed occupancy in the UAE hit 74%, up from 71% the previous year. Even as a 3% rise only sounds modest, in a network of this size, it’s what turns heavy overhead into healthy profit. That growth is backed by some serious speed, as inpatient and outpatient volumes sprinted, up 14% and 15% y/y, respectively.
More importantly, the 17% jump in surgical volumes suggest they are capturing higher-complexity (and higher-margin) cases, not just routine check-ups. This surgical growth is directly fueling the bottom line, as seen in the company's latest FY 25 financial performance.
Crossing borders
Pure Health’s FY 25 results signal a transition from a domestic aggregator to an international operator. Revenue rose just 5.7% to AED 27.3bn (from
AED 25.8bn in FY 24). The company cleared AED 2.02bn in profit this year, an 18% jump over last year, showing they're still raking it in even with the taxman taking a bigger bite.
The €800m acquisition of a 60% stake in Hellenic Healthcare Group (HHG) provided an immediate Q4 boost, contributing AED 742m in revenue and AED 152m in EBITDA. This move, alongside bolt-on buys for Circle Health in the UK, shifts roughly 50% of the group's asset base outside the UAE.
Mind the gap
At AED 2.2, the stock is still bearing the scars of a rough year. Down 23% over the last 12 months and trading well short of its AED 3.1 high. ICYMI, the current price tag starts to look like a massive disconnect when you take a peek under the hood.
The market is pricing this at a 10.7x multiple on estimated FY 26 earnings, a steep discount to its 18.2x historical norm. While the market is particularly cautious—likely due to earnings risk or general sentiment fatigue—analysts are looking at the greener side of the fence.
Despite a sizeable AED 24bn ($6.6bn) market cap, the market is somewhat cautious - either regarding earnings delivery risk, sentiment fatigue, or even both.
With six out of seven voting for "Buy", the pros have an average target price of AED 4, i.e. 85% upside potential. This means that either analysts are over- optimistic, or the market is too pessimistic. History shows that these discounts eventually dry up, but only when management starts delivering actual results.
Growing pains
Pure Health is playing a game of Monopoly right now. Sure, the growth looks great on paper, but it comes with its fair share of risks.
The company has spent billions snapping up hospitals in the UK and Greece. However, stitching those different healthcare systems together without curtailing margins is a massive ask. Trading a fat cash pile for strategic assets, which leaves them with very little back-up money if those international bets don't pay off immediately.
Then you’ve got the taxman stepping in, moving from a 9% to a 15% tax rate in the UAE can prove to be a killjoy for the bottom line.
FY 25 looks like the year that Pure Health stopped building and started tuning. From here, returns depend less on growth headlines and more on whether management can squeeze more productivity and higher-value care out of what they already own.
